URSA-QUALITY-OMW: Osteoporosis Mgmt in Women With a Fracture (OMW)

Measure Description

The percentage of women 67–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the 180 days (6 months) after the fracture. Unadjusted Certified Measure 2c5589f1-0021-44d3-a221-1a0b5ec5a114

Metadata

• Measure Type: Rate Measure
• Temporal Structure: Entity
• Component Class: Long-Form
• Denominator Case Field: Patient ID, Output NCQA Payer Type Code
• Target Direction: Down

Denominator Description

Women aged 67 to 85 with a fracture in the 18-month period ending 6 months prior to the snapshot date.

Numerator Description

Qualifying denominator patients with either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the 180 days (6 months) after the fracture.

*HEDIS® is a registered trademark of the National Committee for Quality Assurance